NBJ: From a marketer’s perspective, what was it like to be involved in the NIH’s Glucosamine/chondroitin Arthritis Intervention Trial of glucosamine-chondroitin and knee osteoarthritis?
NL: For marketing purposes, it is always important to analyze your company’s position and message strategically in relation to the outcome of any research. Our direct involvement in the GAIT study was limited to helping the primary investigator source pharmaceutical grade chondroitin.
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.